Skip to content

A multi-center clinical study on patent technology of

A multi-center clinical study on patent technology of

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-14005279
Enrollment
Unknown
Registered
2014-06-24
Start date
2014-11-10
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinea pedis

Interventions

Sponsors

Jiangsu Province Hospital of TCM
Lead Sponsor

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged =18 years old; 2. Patients with positive clinical symptoms and positive signs; 3. Patients with positive results of fungal microscopy.

Exclusion criteria

Exclusion criteria: 1. Patients with refractory tinea pedis or achieving no effect after local treatment; 2. Patients with hyperkeratotic tinea pedis; 3. Patients with tinea pedis whose blister skin is too thick to be prickled; 4. Patients complicated with other obvious skin diseases that may affect efficacy evaluation (such as contact dermatitis, eczema, palmoplantar pustulosis, stage II syphilis); 5. Patients with other serious systemic diseases; 6. Patients systemically applied with antifungal and antibacterial drugs in previous 4 weeks; 7. Patients locally applied with antifungal and antibacterial drugs in previous 2 weeks; 8. Pregnant and lactating women; 9. Patients with drug allergy (allergy to ammonium salt).

Design outcomes

Primary

MeasureTime frame
pruritus;rash;fungus sticked;

Countries

China

Contacts

Public ContactMin Zhongsheng/Yang Bin/Zhang Xibao
minzhsh@sina.com+86 13952091800/+86 020-87631390

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026